Bone metabolism markers in young high-performance athletes
https://doi.org/10.47183/mes.2025-256
Abstract
Introduction. When assessing bone metabolism markers in athletes under the age of 18, it should be borne in mind that, in comparison with adults, the pediatric population is characterized by higher values of these markers. Their maximum increase during puberty coincides with peak bone mass gain.
Objective. To evaluate bone metabolism status in healthy high-performance athletes under the age of 18 based on the levels of C-terminal telopeptide (β-CrossLaps), osteocalcin, and N-terminal propeptide human procollagen type 1 (P1NP) in the blood serum.
Materials and methods. A single-center, сross-sectional study involved 383 juvenile athletes aged 13–18 years (248 girls and 135 boys; average age 15.2 [14.0; 16.1] years) from Russian national sports teams. The study was conducted in the period from March 2021 to July 2023. All athletes were divided into groups according to age and gender. The male groups were as follows: 13.1–14.0 years old (n = 3); 14.1–15.0 years old (n = 11); 15.1–16.0 years old (n = 43); 16.1–17.0 years old (n = 42); and 17.1–18.0 years old (n = 36). The female groups were as follows: 13.1–14.0 years old (n = 17); 14.1–15.0 years old (n = 51); 15.1–16.0 years old (n = 65); 16.1–17.0 years old (n = 59); and 17.1–18.0 years old (n = 56). The serum levels of osteocalcin, C-terminal telopeptide, and procollagen type 1 were evaluated in all athletes. The sexual maturity rating (SMR) was assessed according to the Tanner Scale. Statistical data processing was performed using the Statistica 10.0 software package (StatSoft Inc.; USA).
Results. The maximum values of β-CrossLaps in boys (2.27 [1.14; 3.45] ng/mL) and girls (1.55 [1.10; 2.02] ng/mL) were observed at the age of 13–14 years. The levels of osteocalcin and P1NP in young high-performance athletes corresponded to the standards for children with a normal level of physical activity. The maximum values of P1NP were revealed at the age of 13–14 years in both male (767.8 [148.1; 1142.4] ng/ mL) and female (450.5 [268.6; 569.3] ng/mL) groups. In boys, the maximum values of osteocalcin (125 [89; 144] ng/mL) were detected at the age of 14–15 years; in girls (86 [62; 131] ng/mL) — at the age of 13–14 years.
Conclusions. In young high-performance athletes, the β-CrossLaps level as the main marker of bone resorption significantly exceeds the population norms for children and adolescents with a normal level of physical activity. When assessing the level of β-CrossLaps, osteocalcin, and P1NP, reference values should be adjusted to account for the gender and sexual maturity stage of athletes. The data obtained can be used when interpreting the results of an in-depth medical examination of athletes from Russian national sports teams to identify bone remodeling disorders.
About the Authors
E. P. IsaevaRussian Federation
Moscow
P. L. Okorokov
Russian Federation
Moscow
S. A. Stolyarova
Russian Federation
Moscow
S. O. Kluchnikov
Russian Federation
Moscow
I. V. Zyabkin
Russian Federation
Moscow
M. R. Isaev
Russian Federation
Moscow
V. S. Fechenko
Russian Federation
Moscow
References
1. Kiseleva NG, Taranushenko TE, Golubenko NK. Diagnosis of osteoporosis at an early age. Medical Council. 2020;(1):179–86 (In Russ.). https://doi.org/10.21518/2079-701X-2020-1-186-193
2. Mountjoy M, Ackerman KE, Bailey DM, Burke LM, Constantini N, Hackney AC, et al. 2023 International Olympic Committee’s (IOC) consensus statement on Relative Energy Deficiency in Sport (REDs). British Journal of Sports Medicine. 2023;57(17):1073–97. https://doi.org/10.1136/bjsports-2023-106994
3. Mountjoy M, Sundgot-Borgen J, Burke L, Ackerman KE, Blauwet C, Constantini N, et al. International Olympic Committee (IOC) consensus statement on relative energy deficiency in sport (RED-S): 2018 update. International journal of sport nutrition and exercise metabolism. 2018;28(4):316–31. https://doi.org/10.1123/ijsnem.2018-0136
4. Christo K, Prabhakaran R, Lamparello B, Cord J, Miller KK, Goldstein MA, et al. Bone metabolism in adolescent athletes with amenorrhea, athletes with eumenorrhea, and control subjects. Pediatrics. 2008;121(6):1127–36. https://doi.org/10.1542/peds.2007-2392
5. Kaga M, Takahashi K, Ishihara T, Suzuki H, Tanaka H, Seino Y, et al. Bone assessment of female long-distance runners. Journal of Bone and Mineral Metabolism. 2004;22(5):509–13. https://doi.org/10.1007/s00774-004-0515-1
6. Hackney AC, Constantini NW. Endocrinology of Physical Activity and Sport. 3 rd ed. Cham: Humana press;2020. https://doi.org/10.1007/978-3-030-33376-8
7. Yang G, Lee WYW, Hung ALH, Tang MF, Li X, Kong APS, et al. Association of serum 25(OH)Vit-D levels with risk of pediatric fractures: a systematic review and meta-analysis. Osteoporosis International. 2021;32(7):1287–1300. https://doi.org/10.1007/s00198-020-05814-1
8. Isaeva EP, Okorokov PL, Zyabkin IV. Secondary hyperparathyroidism associated with vitamin D deficiency in young highly trained athletes. Extreme Medicine. 2024; 26(2):76–82 (In Russ.). https://doi.org/10.47183/mes.2024.033
9. Grishina ZhV, Klyuchnikov SO, Feshchenko VS, Zholinskiy AV. Calculation of reference intervals of blood parameters in children and adolescents: projects review. Extreme Medicine. 2023;25(1):4–11 (In Russ.). https://doi.org/10.47183/mes.2023.008
10. Grishina ZhV, Klyuchnikov SO, Feshchenko VS, Zholinsky AV, Okorokov PL. Reference ranges of biochemical blood parameters in juvenile athletes. Rossiyskiy Vestnik Perinatologii i Pediatrii. 2022;67(4):60–68 (In Russ.). https://doi.org/10.21508/1027-4065-2022-67-4-60-68
11. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Archives of disease in childhood. 1976;51(3):170. https://doi.org/10.1136/adc.51.3.170
12. Chubb SAP, Vasikaran SD, Gillett MJ. Reference intervals for plasma β-CTX and P1NP in children: A systematic review and pooled estimates. Clinical Biochemistry. 2023;(118):110582. https://doi.org/10.1016/j.clinbiochem.2023.05.001
13. Bayer M. Reference values of osteocalcin and procollagen type I N-propeptide plasma levels in a healthy Central European population aged 0–18 years. Osteoporosis International. 2014;25(2):729–36. https://doi.org/10.1007/s00198-013-2485-4
14. Crofton PM, Evans N, Taylor MR, Holland CV. Serum CrossLaps: pediatric reference intervals from birth to 19 years of age. Clinical Chemistry. 2002;48(4):671–3. http://dx.doi.org/10.1093/clinchem/48.4.671
15. Kljuchnikov SO, Kravchuk DA, Ogannisyan MG. Osteoporosis and its actuality for child sports medicine. Russian Bulletin of Perinatology and Pediatrics. 2017; 62:(3):112–20 (in Russ.). https://doi.org/10.21508/1027-4065-2016-61-3-112-120
Supplementary files
Review
For citations:
Isaeva E.P., Okorokov P.L., Stolyarova S.A., Kluchnikov S.O., Zyabkin I.V., Isaev M.R., Fechenko V.S. Bone metabolism markers in young high-performance athletes. Extreme Medicine. (In Russ.) https://doi.org/10.47183/mes.2025-256